Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy CMO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Stem Cell
1.2.3 Non-Stem Cell
1.3 Market by Application
1.3.1 Global Cell Therapy CMO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Commercial
1.3.3 Academic Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy CMO Market Perspective (2018-2033)
2.2 Global Cell Therapy CMO Growth Trends by Region
2.2.1 Cell Therapy CMO Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cell Therapy CMO Historic Market Size by Region (2018-2023)
2.2.3 Cell Therapy CMO Forecasted Market Size by Region (2024-2033)
2.3 Cell Therapy CMO Market Dynamics
2.3.1 Cell Therapy CMO Industry Trends
2.3.2 Cell Therapy CMO Market Drivers
2.3.3 Cell Therapy CMO Market Challenges
2.3.4 Cell Therapy CMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cell Therapy CMO by Players
3.1.1 Global Cell Therapy CMO Revenue by Players (2018-2023)
3.1.2 Global Cell Therapy CMO Revenue Market Share by Players (2018-2023)
3.2 Global Cell Therapy CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cell Therapy CMO, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Cell Therapy CMO Market Concentration Ratio
3.4.1 Global Cell Therapy CMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy CMO Revenue in 2022
3.5 Global Key Players of Cell Therapy CMO Head office and Area Served
3.6 Global Key Players of Cell Therapy CMO, Product and Application
3.7 Global Key Players of Cell Therapy CMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Therapy CMO Breakdown Data by Type
4.1 Global Cell Therapy CMO Historic Market Size by Type (2018-2023)
4.2 Global Cell Therapy CMO Forecasted Market Size by Type (2024-2033)
5 Cell Therapy CMO Breakdown Data by Application
5.1 Global Cell Therapy CMO Historic Market Size by Application (2018-2023)
5.2 Global Cell Therapy CMO Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cell Therapy CMO Market Size (2018-2033)
6.2 North America Cell Therapy CMO Market Size by Type
6.2.1 North America Cell Therapy CMO Market Size by Type (2018-2023)
6.2.2 North America Cell Therapy CMO Market Size by Type (2024-2033)
6.2.3 North America Cell Therapy CMO Market Share by Type (2018-2033)
6.3 North America Cell Therapy CMO Market Size by Application
6.3.1 North America Cell Therapy CMO Market Size by Application (2018-2023)
6.3.2 North America Cell Therapy CMO Market Size by Application (2024-2033)
6.3.3 North America Cell Therapy CMO Market Share by Application (2018-2033)
6.4 North America Cell Therapy CMO Market Size by Country
6.4.1 North America Cell Therapy CMO Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Cell Therapy CMO Market Size by Country (2018-2023)
6.4.3 North America Cell Therapy CMO Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Cell Therapy CMO Market Size (2018-2033)
7.2 Europe Cell Therapy CMO Market Size by Type
7.2.1 Europe Cell Therapy CMO Market Size by Type (2018-2023)
7.2.2 Europe Cell Therapy CMO Market Size by Type (2024-2033)
7.2.3 Europe Cell Therapy CMO Market Share by Type (2018-2033)
7.3 Europe Cell Therapy CMO Market Size by Application
7.3.1 Europe Cell Therapy CMO Market Size by Application (2018-2023)
7.3.2 Europe Cell Therapy CMO Market Size by Application (2024-2033)
7.3.3 Europe Cell Therapy CMO Market Share by Application (2018-2033)
7.4 Europe Cell Therapy CMO Market Size by Country
7.4.1 Europe Cell Therapy CMO Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Cell Therapy CMO Market Size by Country (2018-2023)
7.4.3 Europe Cell Therapy CMO Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cell Therapy CMO Market Size (2018-2033)
8.2 China Cell Therapy CMO Market Size by Type
8.2.1 China Cell Therapy CMO Market Size by Type (2018-2023)
8.2.2 China Cell Therapy CMO Market Size by Type (2024-2033)
8.2.3 China Cell Therapy CMO Market Share by Type (2018-2033)
8.3 China Cell Therapy CMO Market Size by Application
8.3.1 China Cell Therapy CMO Market Size by Application (2018-2023)
8.3.2 China Cell Therapy CMO Market Size by Application (2024-2033)
8.3.3 China Cell Therapy CMO Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Cell Therapy CMO Market Size (2018-2033)
9.2 Asia Cell Therapy CMO Market Size by Type
9.2.1 Asia Cell Therapy CMO Market Size by Type (2018-2023)
9.2.2 Asia Cell Therapy CMO Market Size by Type (2024-2033)
9.2.3 Asia Cell Therapy CMO Market Share by Type (2018-2033)
9.3 Asia Cell Therapy CMO Market Size by Application
9.3.1 Asia Cell Therapy CMO Market Size by Application (2018-2023)
9.3.2 Asia Cell Therapy CMO Market Size by Application (2024-2033)
9.3.3 Asia Cell Therapy CMO Market Share by Application (2018-2033)
9.4 Asia Cell Therapy CMO Market Size by Region
9.4.1 Asia Cell Therapy CMO Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Cell Therapy CMO Market Size by Region (2018-2023)
9.4.3 Asia Cell Therapy CMO Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cell Therapy CMO Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Cell Therapy CMO Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cell Therapy CMO Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Cell Therapy CMO Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Cell Therapy CMO Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Cell Therapy CMO Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cell Therapy CMO Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Cell Therapy CMO Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Cell Therapy CMO Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Cell Therapy CMO Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cell Therapy CMO Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Cell Therapy CMO Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Cell Therapy CMO Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Cell Therapy CMO Introduction
11.1.4 Charles River Revenue in Cell Therapy CMO Business (2018-2023)
11.1.5 Charles River Recent Developments
11.2 The Discovery Labs
11.2.1 The Discovery Labs Company Details
11.2.2 The Discovery Labs Business Overview
11.2.3 The Discovery Labs Cell Therapy CMO Introduction
11.2.4 The Discovery Labs Revenue in Cell Therapy CMO Business (2018-2023)
11.2.5 The Discovery Labs Recent Developments
11.3 BIOCENTRIQ
11.3.1 BIOCENTRIQ Company Details
11.3.2 BIOCENTRIQ Business Overview
11.3.3 BIOCENTRIQ Cell Therapy CMO Introduction
11.3.4 BIOCENTRIQ Revenue in Cell Therapy CMO Business (2018-2023)
11.3.5 BIOCENTRIQ Recent Developments
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Details
11.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Introduction
11.4.4 FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy CMO Business (2018-2023)
11.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments
11.5 Exothera
11.5.1 Exothera Company Details
11.5.2 Exothera Business Overview
11.5.3 Exothera Cell Therapy CMO Introduction
11.5.4 Exothera Revenue in Cell Therapy CMO Business (2018-2023)
11.5.5 Exothera Recent Developments
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Details
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec Cell Therapy CMO Introduction
11.6.4 WuXi AppTec Revenue in Cell Therapy CMO Business (2018-2023)
11.6.5 WuXi AppTec Recent Developments
11.7 Pharmaron
11.7.1 Pharmaron Company Details
11.7.2 Pharmaron Business Overview
11.7.3 Pharmaron Cell Therapy CMO Introduction
11.7.4 Pharmaron Revenue in Cell Therapy CMO Business (2018-2023)
11.7.5 Pharmaron Recent Developments
11.8 OBiO
11.8.1 OBiO Company Details
11.8.2 OBiO Business Overview
11.8.3 OBiO Cell Therapy CMO Introduction
11.8.4 OBiO Revenue in Cell Therapy CMO Business (2018-2023)
11.8.5 OBiO Recent Developments
11.9 Cell Therapies
11.9.1 Cell Therapies Company Details
11.9.2 Cell Therapies Business Overview
11.9.3 Cell Therapies Cell Therapy CMO Introduction
11.9.4 Cell Therapies Revenue in Cell Therapy CMO Business (2018-2023)
11.9.5 Cell Therapies Recent Developments
11.10 AGC Biologics
11.10.1 AGC Biologics Company Details
11.10.2 AGC Biologics Business Overview
11.10.3 AGC Biologics Cell Therapy CMO Introduction
11.10.4 AGC Biologics Revenue in Cell Therapy CMO Business (2018-2023)
11.10.5 AGC Biologics Recent Developments
11.11 Cytiva
11.11.1 Cytiva Company Details
11.11.2 Cytiva Business Overview
11.11.3 Cytiva Cell Therapy CMO Introduction
11.11.4 Cytiva Revenue in Cell Therapy CMO Business (2018-2023)
11.11.5 Cytiva Recent Developments
11.12 Helixmith
11.12.1 Helixmith Company Details
11.12.2 Helixmith Business Overview
11.12.3 Helixmith Cell Therapy CMO Introduction
11.12.4 Helixmith Revenue in Cell Therapy CMO Business (2018-2023)
11.12.5 Helixmith Recent Developments
11.13 ThermoGenesis
11.13.1 ThermoGenesis Company Details
11.13.2 ThermoGenesis Business Overview
11.13.3 ThermoGenesis Cell Therapy CMO Introduction
11.13.4 ThermoGenesis Revenue in Cell Therapy CMO Business (2018-2023)
11.13.5 ThermoGenesis Recent Developments
11.14 Anemocyte
11.14.1 Anemocyte Company Details
11.14.2 Anemocyte Business Overview
11.14.3 Anemocyte Cell Therapy CMO Introduction
11.14.4 Anemocyte Revenue in Cell Therapy CMO Business (2018-2023)
11.14.5 Anemocyte Recent Developments
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Details
11.15.2 Thermo Fisher Scientific Business Overview
11.15.3 Thermo Fisher Scientific Cell Therapy CMO Introduction
11.15.4 Thermo Fisher Scientific Revenue in Cell Therapy CMO Business (2018-2023)
11.15.5 Thermo Fisher Scientific Recent Developments
11.16 CBM
11.16.1 CBM Company Details
11.16.2 CBM Business Overview
11.16.3 CBM Cell Therapy CMO Introduction
11.16.4 CBM Revenue in Cell Therapy CMO Business (2018-2023)
11.16.5 CBM Recent Developments
11.17 Bio Elpida
11.17.1 Bio Elpida Company Details
11.17.2 Bio Elpida Business Overview
11.17.3 Bio Elpida Cell Therapy CMO Introduction
11.17.4 Bio Elpida Revenue in Cell Therapy CMO Business (2018-2023)
11.17.5 Bio Elpida Recent Developments
11.18 Genezen
11.18.1 Genezen Company Details
11.18.2 Genezen Business Overview
11.18.3 Genezen Cell Therapy CMO Introduction
11.18.4 Genezen Revenue in Cell Therapy CMO Business (2018-2023)
11.18.5 Genezen Recent Developments
11.19 CCRM
11.19.1 CCRM Company Details
11.19.2 CCRM Business Overview
11.19.3 CCRM Cell Therapy CMO Introduction
11.19.4 CCRM Revenue in Cell Therapy CMO Business (2018-2023)
11.19.5 CCRM Recent Developments
11.20 RoslinCT
11.20.1 RoslinCT Company Details
11.20.2 RoslinCT Business Overview
11.20.3 RoslinCT Cell Therapy CMO Introduction
11.20.4 RoslinCT Revenue in Cell Therapy CMO Business (2018-2023)
11.20.5 RoslinCT Recent Developments
11.21 GenScript ProBio
11.21.1 GenScript ProBio Company Details
11.21.2 GenScript ProBio Business Overview
11.21.3 GenScript ProBio Cell Therapy CMO Introduction
11.21.4 GenScript ProBio Revenue in Cell Therapy CMO Business (2018-2023)
11.21.5 GenScript ProBio Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cell Therapy CMO Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Stem Cell
Table 3. Key Players of Non-Stem Cell
Table 4. Global Cell Therapy CMO Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Cell Therapy CMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Cell Therapy CMO Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Cell Therapy CMO Market Share by Region (2018-2023)
Table 8. Global Cell Therapy CMO Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Cell Therapy CMO Market Share by Region (2024-2033)
Table 10. Cell Therapy CMO Market Trends
Table 11. Cell Therapy CMO Market Drivers
Table 12. Cell Therapy CMO Market Challenges
Table 13. Cell Therapy CMO Market Restraints
Table 14. Global Cell Therapy CMO Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Cell Therapy CMO Revenue Share by Players (2018-2023)
Table 16. Global Top Cell Therapy CMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CMO as of 2022)
Table 17. Global Cell Therapy CMO Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Cell Therapy CMO Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Cell Therapy CMO, Headquarters and Area Served
Table 20. Global Key Players of Cell Therapy CMO, Product and Application
Table 21. Global Key Players of Cell Therapy CMO, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Therapy CMO Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Cell Therapy CMO Revenue Market Share by Type (2018-2023)
Table 25. Global Cell Therapy CMO Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Cell Therapy CMO Revenue Market Share by Type (2024-2033)
Table 27. Global Cell Therapy CMO Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Cell Therapy CMO Revenue Share by Application (2018-2023)
Table 29. Global Cell Therapy CMO Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Cell Therapy CMO Revenue Share by Application (2024-2033)
Table 31. North America Cell Therapy CMO Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Cell Therapy CMO Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Cell Therapy CMO Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Cell Therapy CMO Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Cell Therapy CMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Cell Therapy CMO Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Cell Therapy CMO Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Cell Therapy CMO Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Cell Therapy CMO Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Cell Therapy CMO Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Cell Therapy CMO Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Cell Therapy CMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Cell Therapy CMO Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Cell Therapy CMO Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Cell Therapy CMO Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Cell Therapy CMO Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Cell Therapy CMO Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Cell Therapy CMO Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Cell Therapy CMO Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Cell Therapy CMO Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Cell Therapy CMO Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Cell Therapy CMO Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Cell Therapy CMO Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Cell Therapy CMO Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Cell Therapy CMO Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Cell Therapy CMO Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Cell Therapy CMO Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Cell Therapy CMO Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Cell Therapy CMO Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Cell Therapy CMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Cell Therapy CMO Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Cell Therapy CMO Market Size by Country (2024-2033) & (US$ Million)
Table 63. Charles River Company Details
Table 64. Charles River Business Overview
Table 65. Charles River Cell Therapy CMO Product
Table 66. Charles River Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 67. Charles River Recent Developments
Table 68. The Discovery Labs Company Details
Table 69. The Discovery Labs Business Overview
Table 70. The Discovery Labs Cell Therapy CMO Product
Table 71. The Discovery Labs Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 72. The Discovery Labs Recent Developments
Table 73. BIOCENTRIQ Company Details
Table 74. BIOCENTRIQ Business Overview
Table 75. BIOCENTRIQ Cell Therapy CMO Product
Table 76. BIOCENTRIQ Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 77. BIOCENTRIQ Recent Developments
Table 78. FUJIFILM Diosynth Biotechnologies Company Details
Table 79. FUJIFILM Diosynth Biotechnologies Business Overview
Table 80. FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Product
Table 81. FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 82. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 83. Exothera Company Details
Table 84. Exothera Business Overview
Table 85. Exothera Cell Therapy CMO Product
Table 86. Exothera Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 87. Exothera Recent Developments
Table 88. WuXi AppTec Company Details
Table 89. WuXi AppTec Business Overview
Table 90. WuXi AppTec Cell Therapy CMO Product
Table 91. WuXi AppTec Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 92. WuXi AppTec Recent Developments
Table 93. Pharmaron Company Details
Table 94. Pharmaron Business Overview
Table 95. Pharmaron Cell Therapy CMO Product
Table 96. Pharmaron Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 97. Pharmaron Recent Developments
Table 98. OBiO Company Details
Table 99. OBiO Business Overview
Table 100. OBiO Cell Therapy CMO Product
Table 101. OBiO Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 102. OBiO Recent Developments
Table 103. Cell Therapies Company Details
Table 104. Cell Therapies Business Overview
Table 105. Cell Therapies Cell Therapy CMO Product
Table 106. Cell Therapies Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 107. Cell Therapies Recent Developments
Table 108. AGC Biologics Company Details
Table 109. AGC Biologics Business Overview
Table 110. AGC Biologics Cell Therapy CMO Product
Table 111. AGC Biologics Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 112. AGC Biologics Recent Developments
Table 113. Cytiva Company Details
Table 114. Cytiva Business Overview
Table 115. Cytiva Cell Therapy CMO Product
Table 116. Cytiva Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 117. Cytiva Recent Developments
Table 118. Helixmith Company Details
Table 119. Helixmith Business Overview
Table 120. Helixmith Cell Therapy CMO Product
Table 121. Helixmith Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 122. Helixmith Recent Developments
Table 123. ThermoGenesis Company Details
Table 124. ThermoGenesis Business Overview
Table 125. ThermoGenesis Cell Therapy CMO Product
Table 126. ThermoGenesis Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 127. ThermoGenesis Recent Developments
Table 128. Anemocyte Company Details
Table 129. Anemocyte Business Overview
Table 130. Anemocyte Cell Therapy CMO Product
Table 131. Anemocyte Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 132. Anemocyte Recent Developments
Table 133. Thermo Fisher Scientific Company Details
Table 134. Thermo Fisher Scientific Business Overview
Table 135. Thermo Fisher Scientific Cell Therapy CMO Product
Table 136. Thermo Fisher Scientific Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 137. Thermo Fisher Scientific Recent Developments
Table 138. CBM Company Details
Table 139. CBM Business Overview
Table 140. CBM Cell Therapy CMO Product
Table 141. CBM Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 142. CBM Recent Developments
Table 143. Bio Elpida Company Details
Table 144. Bio Elpida Business Overview
Table 145. Bio Elpida Cell Therapy CMO Product
Table 146. Bio Elpida Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 147. Bio Elpida Recent Developments
Table 148. Genezen Company Details
Table 149. Genezen Business Overview
Table 150. Genezen Cell Therapy CMO Product
Table 151. Genezen Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 152. Genezen Recent Developments
Table 153. CCRM Company Details
Table 154. CCRM Business Overview
Table 155. CCRM Cell Therapy CMO Product
Table 156. CCRM Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 157. CCRM Recent Developments
Table 158. RoslinCT Company Details
Table 159. RoslinCT Business Overview
Table 160. RoslinCT Cell Therapy CMO Product
Table 161. RoslinCT Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 162. RoslinCT Recent Developments
Table 163. GenScript ProBio Company Details
Table 164. GenScript ProBio Business Overview
Table 165. GenScript ProBio Cell Therapy CMO Product
Table 166. GenScript ProBio Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 167. GenScript ProBio Recent Developments
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Therapy CMO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Cell Therapy CMO Market Share by Type: 2022 VS 2033
Figure 3. Stem Cell Features
Figure 4. Non-Stem Cell Features
Figure 5. Global Cell Therapy CMO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Cell Therapy CMO Market Share by Application: 2022 VS 2033
Figure 7. Commercial Case Studies
Figure 8. Academic Research Case Studies
Figure 9. Others Case Studies
Figure 10. Cell Therapy CMO Report Years Considered
Figure 11. Global Cell Therapy CMO Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Cell Therapy CMO Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Cell Therapy CMO Market Share by Region: 2022 VS 2033
Figure 14. Global Cell Therapy CMO Market Share by Players in 2022
Figure 15. Global Top Cell Therapy CMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CMO as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Cell Therapy CMO Revenue in 2022
Figure 17. North America Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Cell Therapy CMO Market Share by Type (2018-2033)
Figure 19. North America Cell Therapy CMO Market Share by Application (2018-2033)
Figure 20. North America Cell Therapy CMO Market Share by Country (2018-2033)
Figure 21. United States Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Cell Therapy CMO Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Cell Therapy CMO Market Share by Type (2018-2033)
Figure 25. Europe Cell Therapy CMO Market Share by Application (2018-2033)
Figure 26. Europe Cell Therapy CMO Market Share by Country (2018-2033)
Figure 27. Germany Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Cell Therapy CMO Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Cell Therapy CMO Market Share by Type (2018-2033)
Figure 35. China Cell Therapy CMO Market Share by Application (2018-2033)
Figure 36. Asia Cell Therapy CMO Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Cell Therapy CMO Market Share by Type (2018-2033)
Figure 38. Asia Cell Therapy CMO Market Share by Application (2018-2033)
Figure 39. Asia Cell Therapy CMO Market Share by Region (2018-2033)
Figure 40. Japan Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Cell Therapy CMO Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Cell Therapy CMO Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Cell Therapy CMO Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Cell Therapy CMO Market Share by Country (2018-2033)
Figure 50. Brazil Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Cell Therapy CMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Charles River Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 57. The Discovery Labs Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 58. BIOCENTRIQ Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 59. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 60. Exothera Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 61. WuXi AppTec Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 62. Pharmaron Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 63. OBiO Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 64. Cell Therapies Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 65. AGC Biologics Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 66. Cytiva Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 67. Helixmith Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 68. ThermoGenesis Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 69. Anemocyte Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 70. Thermo Fisher Scientific Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 71. CBM Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 72. Bio Elpida Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 73. Genezen Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 74. CCRM Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 75. RoslinCT Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 76. GenScript ProBio Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed